Insights PreviousNextSubscribe to HTA QuarterlyGet at-a-glance updates on important HTA decisions. Each edition of the HTA Quarterly provides insight into the evolving perspectives and priorities for HTAs.Read MoreSubscribe to Health Policy WeeklyRecaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry.Read More1 of 0 Items Emerging Access Barriers and Evidence Requirements for Oncology Therapies: Experiences Across Three MarketsXcenda hosted an educational symposium titled, Emerging Access Barriers and Evidence Requirements for Oncology Therapies: Experiences Across Three Countries, at ISPOR's 19th Annual Meeting on Tuesday, June 3, 2014. Download the presentation slides here. MoreCurrent and Future Access Challenges for Specialty and Biotechnology ProductsIn this webinar, recorded on June 9, 2014, Trent McLaughlin, BSc (Pharm), PhD, and Marie-Josée Martel, PhD, discuss access challenges for specialty and biotech products in 3 key markets: the US, Canada and Germany. MoreTry Out the HTA Decision MapXcenda's Decision Map makes it easy to stay informed on key HTA decisions from Australia, Canada, France, Germany, and the United Kingdom. MoreHTA Quarterly Archive: Insights to Bridge Science and PolicyFind articles from current and past issues of the HTA Quarterly, Xcenda's e-newsletter written specifically by and for health economics and market access professionals. MoreHealth Policy Weekly ArchiveMiss a recent issue? Get up to date with the latest regulatory and legislative happenings and news that impact stakeholders in the healthcare industry. MoreCACTRACXcenda offers manufacturers a complimentary, efficient, and user-friendly resource to proactively monitor all Medicare CAC Meetings and related LCD information for all 15 Medicare Administrative Contractor (MAC) jurisdictions. More Explore More InsightsWe invite you to explore our library of articles, webcasts, white papers, and more.